Machine Learning

A new biotech player is advancing a first-in-class cancer drug that combines two payloads to fight tumors that have become resistant to current therapies.

Apryse's new ICR technology lets companies digitize handwritten documents securely in-house, unlocking a final frontier of data for AI automation.

Backed by Bain Capital and a veteran team, the new biotech has a de-risked pipeline from Bristol Myers Squibb aimed at transforming care for lupus and more.

Investors eye BioCryst's May 6th report for insights into ORLADEYO's growth, a pivotal acquisition, and its strategy in the competitive rare disease market.

Scientists have created the first continent-wide map of bird flu's spread, explaining human cases and assessing the risk of a future pandemic.

Backed by DJI's tech prowess, Amflow unveils its PX and PR eMTBs with monstrous power, smart features, and lightweight frames, aiming to redefine the market.

Pre-rolled joints are now the #1 cannabis product by units sold, a new report reveals. Discover the strategies and innovations fueling this market takeover.

A new service from Alida Biosciences simultaneously reads three key RNA modifications, opening a new frontier in disease diagnostics and biological research.

Promising early safety data for a novel drug, KM-023, brings a potential first-ever targeted treatment for the devastating Olmsted syndrome a step closer.

With strategic cargo theft costing billions, a new AI platform offers real-time biometric verification to secure shipments before they ever move.

Instem hires AI regulatory expert Szczepan Baran to embed submission-ready science into preclinical R&D, aiming to move beyond hype to validated results.

At a major oncology conference, Zephyr AI will showcase AI that predicts patient response to targeted therapies, aiming to personalize cancer treatment.

A new 'pure-play' space tech ETF, ORBX, aims to give investors a direct route into the booming commercial space race. Here is how it works.

A first-in-class AI software, neuropacs™, gains FDA clearance, promising to help doctors differentiate complex Parkinsonian syndromes with high accuracy.

With a massive patent portfolio, Iceotope is tackling the thermal crisis of AI, promising greener, more powerful data centers in a booming $15B market.

New legislation aims to make Upstate New York a quantum tech leader, blending federal support with local innovation to secure America's future.

C-mo Medical Solutions has received European approval for its AI-powered wearable, a device poised to transform respiratory care with objective, private data.

Lobbying spending shattered records at $5.3 billion in 2025, driven by battles over trade, taxes, AI, and a surge in Trump-aligned influence firms.

A new partnership aims to merge broadcast TV with digital ad targeting, promising new revenue for broadcasters but raising questions about consumer privacy.

WisPaper's new AI research agent promises to unify the entire scientific workflow, but as AI enters the lab, it's redefining the role of the researcher.